Ticker: MREO

Snapshot - Mereo BioPharma Group plc (NASDAQ: MREO) What's happening inside: the company is advancing late‑stage rare‑disease programs (setrusumab and alvelestat), progressing Phase 3 activity with partner Ultragenyx, converting debt to equity to reduce interest burden, and recognizing a small li...